Hope for kids with rare brain disease: new drug trial launches
NCT ID NCT07579910
First seen May 20, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study tests a new drug called tralesinidase alfa for children aged 1 to 5 with Sanfilippo syndrome type B, a rare genetic disease that damages the brain. The drug is given directly into the fluid around the brain and aims to slow down thinking and learning problems. About 14 children will take part, and the study will compare the drug to standard care over 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MPS IIIB are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.